Mesenchymal stem cells are known to possess a variety of immune modulatory activities such as suppression of allogeneic responses, as well as induction of T regulatory cells. Mechanisms include expression of IDO and HLA-G. Mesenchymal stem cells have been demonstrated effective in patients with heart failure and are clinically in trials for graft versus host disease.
The current patent teaches the use of mesenchymal... [Read more]
This patent is a continuation of Blasticon's #7,138,275 covering a monocyte-derived stem cell that is capable of differentiating into islets, hepatocytes, and neurons. In the current patent the use of hepatic, or hepatic-like cells derived from these monocytes is covered.
The general coverage of the patent extends to generation and use of a cell capable of expressing albumin that is made by the differentiation of a CD-14 positive, CD-90 positive monocytic derived stem cell.
Covered uses including treatment of cirrhosis... [Read more]
This patent covers the generation of neurons from mesenchymal stem cells, or like the inventor calls them "mesenchymal stromal cells", which is the more politically correct way of naming them.
Very broad claims are issued, the first one being: "A method of producing a neural progenitor cell, said method comprising contacting an isolated bone marrow stromal cell with a compound that induces differentiation of said bone marrow stromal cell, wherein the compound is a cyclic AMP-stimulating compound that increases the... [Read more]
This patent covers methods of extracting an adherent mesenchymal-like stem cells from the Wharton's Jelly of the umbilical cord. The extracted cells are negative for MHC and are termed by the inventors human umbilical cord perivascular (HUCPV) cells. In the examples section the the cells are demonstrated to be capable of differentiating into osteocytes, chondrocytes, adipocytes, and myocytes.
The first independent claim covers "A method of obtaining a population of human umbilical cord perivascular (HUCPV) cells, comprising: (a) obtaining an excised blood vessel... [Read more]
View all stem cell patents